Industry / Mexico
Birmex Ups Vaccine Capacity
April 2008 | Company News AlertIn what could be a significant boost to the self-sufficiency of Mexico's pharmaceutical market, state-owned vaccine maker Laboratorios de Biológicos y Reactivos de México (Birmex) has completed an upgrade of one of its two production facilities. The Instituto Nacional de Virología (INV) has reopened with increased capacity and is expected to be able to meet all domestic demand for polio
Sorry, you must be a subscriber to view this article in full. If you are a subscriber please login.
If you would like to subscribe to Americas Pharma & Healthcare Insight and gain instant access to this article, please click here to subscribe.
If you would like to take a trial to Americas Pharma & Healthcare Insight please click on the trial link below.
